Mendelian susceptibility to mycobacterial diseases is a rare inherited immune condition that makes it harder for the body to fight certain germs, especially mycobacteria from the BCG vaccine and environmental mycobacteria. Many people first hear about Mendelian susceptibility to mycobacterial diseases after a child has unusually severe or repeated infections, and early symptoms of Mendelian susceptibility to mycobacterial diseases often begin in infancy or childhood. Signs can include swollen lymph nodes, fever, poor growth, lung or bone infection, and in some people repeated Salmonella infections. Mendelian susceptibility to mycobacterial diseases is usually lifelong, and the outlook varies because some forms are milder while others can be serious or life-threatening without prompt care. Treatment focuses on antibiotics for infections, careful follow-up, and in some cases immune therapies or a stem cell transplant.
How many people live with Mendelian susceptibility to mycobacterial diseases?
Mendelian susceptibility to mycobacterial disease, an inherited problem with fighting certain bacteria, is so rare that no single reliable estimate is available for how many people are living with it worldwide; major rare-disease sources list its prevalence as unknown rather than giving a global total (Orphanet, 2024). The same is true in the United States, where public rare-disease sources do not provide a firm national count for this condition (Genetic and Rare Diseases Information Center, 2024).
Overview
Mendelian susceptibility to mycobacterial diseasesSymptoms
Mendelian susceptibility to mycobacterial diseases mainly causes repeated, sometimes severe infections from weak mycobacteria, including after the BCG vaccine. Early signs of Mendelian susceptibility to mycobacterial diseases often appear in infancy or childhood, with swollen glands, fever, poor growth, or bone and lung infections.
Outlook and prognosis
For many living with Mendelian susceptibility to mycobacterial diseases, outlook is often good when the condition is recognized early and infections are treated promptly. Prognosis depends on the gene change and infection severity, and some need long-term specialist follow-up.
Causes and risk factors
Mendelian susceptibility to mycobacterial diseases is caused by inherited changes in immune-system genes, sometimes arising new in a child. Risk is highest with a family history. Exposure to BCG vaccine or environmental mycobacteria can trigger illness.
Genetic influences
Genetics are central to Mendelian susceptibility to mycobacterial diseases. It is usually caused by inherited gene changes that weaken key immune signals, so genetic testing often helps confirm the diagnosis and can guide family counseling.
Diagnosis
Diagnosis of Mendelian susceptibility to mycobacterial diseases usually starts with a suggestive infection history and clinical features. Doctors confirm it with immune testing and genetic tests, sometimes alongside family history.
Treatment and drugs
Treatment for Mendelian susceptibility to mycobacterial diseases focuses on clearing infections quickly and preventing them from returning. Many need long courses of carefully chosen antibiotics, and some also receive interferon-gamma. Severe cases may need stem cell transplant.
Symptoms
Some children and adults seem healthy until they develop infections that are unusually severe, slow to clear, or keep coming back. For many people with Mendelian susceptibility to mycobacterial diseases, the main signs involve germs related to tuberculosis or germs commonly found in soil and water that usually do not cause major illness in healthy people. A strong reaction after the BCG vaccine, repeated swollen lymph nodes, fever, poor growth, or ongoing lung, skin, or bone infections can all be clues. The exact features vary by gene change and age, so some people are diagnosed in infancy while others are not recognized until later.
After BCG vaccination, some children develop a sore that does not heal normally or nearby lymph nodes that become large and inflamed. A lingering vaccine reaction can be one of the early features of Mendelian susceptibility to mycobacterial diseases.
Infections from tuberculosis-related germs or mycobacteria found in soil and water may be unusually severe, keep returning, or be hard to clear. Some people first notice this as repeated fevers, an ongoing cough, or infections that spread beyond one body area.
Lymph nodes in the neck, armpit, or groin can stay enlarged for weeks or months when the body struggles to control infection. They may be tender, form a noticeable lump, or sometimes drain through the skin.
Ongoing infection can lead to tiredness, poor appetite, slow weight gain, or slower growth in children. In adults, it may show up more as fatigue, weight loss, or feeling run down for long stretches.
How people usually first notice Mendelian susceptibility to mycobacterial diseases?
Mendelian susceptibility to mycobacterial diseases is usually first noticed in infancy or early childhood, often when a baby or young child becomes unusually sick after the BCG vaccine or develops a serious infection from mycobacteria that usually do not make healthy children very ill. The first signs of Mendelian susceptibility to mycobacterial diseases often include swollen lymph nodes, fever, poor weight gain, ongoing lung or skin infections, or infections that keep coming back or are harder than expected to treat; some children also develop severe tuberculosis or repeated Salmonella infections. Doctors and families usually first suspect something is wrong when these infections seem out of proportion to the child’s age and overall health, especially if there is a family history of similar severe infections.
Types of Mendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseases, or MSMD, is a group of rare inherited immune conditions rather than a single disorder. The main variants of Mendelian susceptibility to mycobacterial diseases are usually defined by which gene in the interferon-γ and IL-12 immune pathway is affected, and by whether that change partly weakens the pathway or nearly shuts it down. This helps explain why some people have milder, more occasional infections, while others become seriously ill after exposure to weak mycobacteria, including the BCG vaccine used in some countries. Not everyone will experience every type.
IFNGR1 complete
This is one of the most severe types of MSMD and happens when cells cannot respond properly to interferon-γ. Serious infections often begin early in life, sometimes after BCG vaccination or exposure to environmental mycobacteria. People may also have repeated infections that are hard to clear.
IFNGR1 partial
In this variant, the interferon-γ receptor still works a little, so illness can be milder than in complete deficiency. Infections with mycobacteria are still common, but they may start later or be easier to control with treatment. Severity can vary a lot from one family member to another.
IFNGR2 deficiency
This variant affects another part of the interferon-γ receptor and can also be complete or partial. Complete forms usually cause early, severe mycobacterial infections, while partial forms often allow some remaining immune function. The pattern can look similar to IFNGR1-related disease, but the gene change is different.
IL12RB1 deficiency
This is one of the more common recognized variants of MSMD and affects how the body helps make or respond to interferon-γ signals. Many living with this form are prone to mycobacterial infection and can also have salmonella infections. Some may not become ill until later childhood, while others are diagnosed much earlier.
IL12B deficiency
This type affects a signal the immune system uses to activate defenses against certain germs. People with this variant can develop infections from weak mycobacteria and may also be more vulnerable to salmonella. It is rare, but it is a well-established cause among the genetic types of MSMD.
STAT1 deficiency
STAT1-related MSMD affects an important step that carries the interferon-γ message inside immune cells. When that signal is severely disrupted, mycobacterial infections can be more serious and more persistent. Milder forms may leave some signaling in place, which can soften the overall picture.
IRF8 deficiency
This rare variant changes a gene involved in developing and directing certain infection-fighting immune cells. Complete deficiency can cause very severe disease in infancy, while partial deficiency may lead to a narrower pattern of infections. Some people mainly come to attention after an unusual reaction to BCG vaccine.
ISG15 deficiency
This form can weaken interferon-γ–dependent immunity and raise the risk of mycobacterial disease. In some families, it is also linked with brain calcifications seen on imaging, although not everyone has noticeable neurologic problems. Symptoms don’t always look the same for everyone.
TYK2 deficiency
TYK2-related MSMD is uncommon and affects signaling used by several immune pathways, including the one important for fighting mycobacteria. Some people mainly have mycobacterial infections, while others also have repeated viral, bacterial, or fungal infections. The exact pattern depends on how much TYK2 function is lost.
X-linked CYBB
This variant is caused by changes in CYBB that can produce an MSMD pattern without the full picture of chronic granulomatous disease. It mainly raises susceptibility to mycobacterial infection, especially in boys, because the gene is on the X chromosome. Family history can offer an important clue in this subtype.
Can I slow down the onset of symptoms?
For Mendelian susceptibility to mycobacterial diseases, the honest answer is usually no: there is no good evidence that diet, exercise, sleep, or other lifestyle changes can meaningfully delay the start of symptoms, because symptoms usually begin after exposure to certain germs in people born with this rare immune problem. What may help is lowering the chance of a first serious infection, which is different from preventing the condition itself; if the condition is known or strongly suspected, doctors often advise avoiding the live BCG tuberculosis vaccine, watching closely for unusual infections, and making an early treatment plan with an immune specialist. These steps cannot guarantee that symptoms will not appear, but they can help many living with this condition get infections recognized and treated sooner.
What genetics can tell you about symptoms
Yes. In Mendelian susceptibility to mycobacterial diseases, the exact gene change can affect which infections people are more likely to get, how early problems begin, and how severe they become, because different changes weaken the body’s interferon-gamma and related immune pathways to different degrees. Many living with this condition mainly develop unusually serious illness from weak mycobacterial germs, such as after the BCG vaccine or from environmental mycobacteria, while some gene changes can also raise the risk of Salmonella infections or, less often, other infections, so symptoms can vary from child to child and even within the same family.
Causes and risk factors
Repeated infections after the BCG vaccine or after contact with tuberculosis can be an early clue to Mendelian susceptibility to mycobacterial diseases. The underlying cause is a harmful gene change that is inherited from a parent or starts new in a child, and it weakens an immune pathway called interferon-γ and IL-12. A family history of Mendelian susceptibility to mycobacterial diseases raises risk, and genetic testing can sometimes clarify personal risk. Illness often starts after exposure to the BCG vaccine, tuberculosis, or related germs found in soil and water. Age, other immune problems, poor nutrition, and crowded living conditions do not cause the condition, but they can raise exposure or make infections harder to fight.
What are the most common causes or risk factors?
Mendelian susceptibility to mycobacterial diseases is usually caused by an inherited gene change that weakens the part of the immune system that should fight certain germs, especially germs related to tuberculosis. The main risk factors are a family history of the condition, parents who are blood relatives, and in some families being male because of the way the changed gene is passed down. There are no known lifestyle causes, but the problem often becomes noticeable only after exposure to certain bacteria, such as the weakened germ used in the BCG vaccine in some countries or similar germs found in soil and water.
Environmental and biological risk factors
For Mendelian susceptibility to mycobacterial diseases, well-established environmental and non-genetic biological risk factors have not been identified. This condition is usually present from birth rather than caused by outside exposures during life. Being exposed to risks in your body or environment doesn’t mean illness is inevitable, but in this case those factors are not known to be the main reason the condition occurs.
Genetic risk factors
In Mendelian susceptibility to mycobacterial diseases, the main risks come from inherited changes in genes that help immune cells respond to certain bacteria. Some risk factors are inherited through our genes. Most of these changes disrupt the interferon-γ and interleukin-12 pathway, and the exact risk depends on which gene is affected and whether one or two altered copies are present.
Family history: Having a close relative with Mendelian susceptibility to mycobacterial diseases raises the chance that the same gene change is present in the family. This matters most when more than one child or relative has had unusual or repeated infections caused by mycobacteria.
Carrier parents: Many forms happen when a child inherits a nonworking copy of the same gene from both parents. In these recessive forms, both parents are often healthy carriers and may not know they carry the variant.
Dominant inheritance: Some forms develop when one altered copy of a gene is enough to disturb immune signaling. These cases may show up across several generations, although symptoms can vary widely even within one family.
X-linked forms: A small number of cases are caused by changes in genes on the X chromosome, including CYBB and IKBKG. These forms often affect boys more often, while mothers may be unaffected carriers or have milder features.
Related parents: When parents are biologically related, they are more likely to share the same rare gene variant. This increases the chance of recessive forms of Mendelian susceptibility to mycobacterial diseases in their children.
Interferon-γ genes: Changes in genes that make interferon-γ or help cells respond to it can strongly raise risk because this signal is central to killing mycobacteria. Variants in IFNGR1, IFNGR2, IFNG, and STAT1 are among the best known genetic causes of Mendelian susceptibility to mycobacterial diseases.
IL-12 pathway: Variants in genes involved in interleukin-12 signaling can weaken the body's ability to build a strong interferon-γ response. Changes in IL12RB1 and IL12B are well-established causes, and IL12RB1-related disease is one of the more common forms.
Other immune genes: Some people have changes in other genes that control the same defense pathway, such as IRF8, ISG15, TYK2, or SPPL2A. These genes are less common causes, but they can still create a clear inherited risk.
New variants: Sometimes the gene change appears for the first time in the affected child and is not found in either parent. This is less common, but it can explain the condition even when there is no family history.
Lifestyle risk factors
Mendelian susceptibility to mycobacterial diseases is inherited, so lifestyle habits do not cause it. However, how lifestyle affects Mendelian susceptibility to mycobacterial diseases can be important because daily habits may influence infection exposure, immune resilience, treatment success, and recovery. The most relevant factors are those that affect nutrition, adherence to care, general immune health, and the chance of delayed recognition of infection.
Poor overall nutrition can weaken immune function and make it harder for the body to respond to mycobacterial infections. Adequate calories, protein, and micronutrients may support recovery, growth, and tolerance of prolonged treatment.
Heavy alcohol use can impair immune defenses and increase the risk of missed doses, drug interactions, or liver problems during antimycobacterial treatment. Limiting alcohol may help protect treatment safety and support more reliable disease control.
Smoking and secondhand smoke can irritate the lungs and reduce local airway defenses, which may worsen respiratory symptoms when mycobacterial infection affects the chest. Avoiding smoke exposure may help preserve lung function and lower complication risk.
Chronic sleep loss can disrupt immune regulation and reduce physical resilience during infection. More regular, adequate sleep may improve energy, recovery, and the ability to cope with long treatment courses.
Risk prevention
For people living with Mendelian susceptibility to mycobacterial diseases, preventing the condition itself is usually not possible because it is caused by an inherited change in the immune system. Prevention focuses instead on lowering the chance of serious infections, spotting problems early, and reducing complications over time. Different people need different prevention strategies—there’s no single formula. Care is usually tailored with an immunology or infectious disease specialist, especially around vaccines, travel, and repeated infections.
Some live vaccines, especially the BCG tuberculosis vaccine, can be risky for people with Mendelian susceptibility to mycobacterial diseases. Vaccine decisions should be made with a specialist so protection is balanced with safety.
Fast treatment of fever, swollen lymph nodes, lingering cough, or skin infections can help stop a mild illness from becoming severe. In many living with Mendelian susceptibility to mycobacterial diseases, these can be early symptoms of Mendelian susceptibility to mycobacterial diseases-related infection problems rather than routine childhood bugs.
Some people may be advised to take preventive antibiotics or other anti-infection medicines to lower the risk of mycobacterial disease. This is most often considered after past infections or when test results suggest higher risk.
Avoiding close contact with known tuberculosis and reducing high-risk exposure to untreated water, soil, or animal sources may help lower infection risk. Prevention is about lowering risk, not eliminating it completely.
Can you prevent Mendelian susceptibility to mycobacterial diseases?
No, you usually cannot prevent Mendelian susceptibility to mycobacterial diseases itself, because it is an inherited immune system problem that people are born with. If it runs in your family, genetic counseling and family testing can help you understand the chance of passing it on. For someone living with it, early diagnosis and avoiding certain risks, such as the BCG vaccine used against tuberculosis when a doctor advises against it, may help lower the chance of serious infections, but this does not prevent the condition.
Transmission
Mendelian susceptibility to mycobacterial diseases is not contagious, so it does not spread from person to person through the air, touch, food, or sex. What can be passed down is the gene change behind it, and how Mendelian susceptibility to mycobacterial diseases is inherited varies by family: sometimes it comes from one parent, sometimes from both.
Many living with Mendelian susceptibility to mycobacterial diseases inherit it from a parent, while in others the gene change happens for the first time in that child. The condition itself is not infectious, but it can make someone much more likely to develop certain mycobacterial infections from the environment or, in some cases, after a live BCG vaccine.
When to test your genes
Consider genetic testing if you or your child has severe, unusual, or repeated infections with BCG vaccine strains, nontuberculous mycobacteria, tuberculosis, or recurrent Salmonella, especially in early childhood. Testing also matters when there is a family history of these infections or known related gene variants, because results can guide treatment and vaccine decisions.
Diagnosis
People with Mendelian susceptibility to mycobacterial diseases are often diagnosed after unusual or repeated infections from normally weak mycobacteria, such as the bacteria used in the BCG vaccine, or from tuberculosis in some families. Because this condition is rare, the diagnosis usually starts with the pattern of infections and immune problems, then is confirmed with specialized testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors look closely at the type, severity, and timing of infections, especially serious illness after BCG vaccination or repeated infections with environmental mycobacteria. This clinical pattern can raise suspicion for the diagnosis of Mendelian susceptibility to mycobacterial diseases.
A detailed family and health history can help show whether similar infections, early severe illness, or related immune problems have happened in relatives. Family history is often a key part of the diagnostic conversation because some forms are inherited.
The exam may look for signs of ongoing infection, swollen lymph nodes, poor growth in children, or complications affecting the lungs, liver, or bones. These findings do not prove the condition on their own, but they help guide further testing.
Blood tests may check white blood cell counts, inflammation, and overall immune function, and other lab tests may help rule out common conditions. These tests help doctors see whether the immune system is broadly affected or whether the problem seems more specific.
How is Mendelian susceptibility to mycobacterial diseases diagnosed?
Mendelian susceptibility to mycobacterial diseases is usually suspected when someone has severe, repeated, or unusual infections caused by germs related to tuberculosis, including illness after the BCG vaccine or infections from mycobacteria found in the environment. Doctors diagnose it by looking at the pattern of these infections, taking a careful personal and family history, and doing blood tests to see whether the body’s infection-fighting signals are working properly. Genetic testing is often used to confirm the diagnosis and find the exact inherited change, but it is usually done alongside these clinical and lab findings, not on its own.
Stages of Mendelian susceptibility to mycobacterial diseases
Mendelian susceptibility to mycobacterial diseases does not have defined progression stages. This is because it is a genetic immune system condition, and what happens over time usually depends on when someone is exposed to certain germs and how severe each infection is, rather than moving through a steady set of stages. Early symptoms of Mendelian susceptibility to mycobacterial diseases often show up as unusual, repeated, or severe infections after exposure to weak forms of mycobacteria, including the bacteria used in the BCG vaccine, and doctors usually diagnose it using the infection history, immune system testing, and genetic testing. Sometimes answers come quickly, while other times it takes longer.
Outlook and prognosis
Outlook in Mendelian susceptibility to mycobacterial diseases varies widely with the specific gene involved, the severity of immune dysfunction, and how quickly infections are recognized and treated. Many affected people can do well with prompt antimycobacterial therapy, careful vaccination planning, and in some cases adjunctive treatments such as interferon-γ, but they may remain at risk for recurrent or severe infections from weakly virulent mycobacteria and sometimes Salmonella. Prognosis is generally better in partial defects than in complete deficiencies, while complete defects of the IFN-γ/IL-12 pathway can cause more severe, persistent disease. Mortality is increased when diagnosis is delayed, infections are disseminated, or the underlying immune defect is severe, especially in early childhood. For selected patients with the most serious forms, hematopoietic stem cell transplantation may improve long-term outcomes, although results depend on the genetic subtype and transplant-related risks. Lifelong follow-up with immunology and infectious disease specialists is usually needed to reduce complications and improve survival.
Long-term effects
For many living with Mendelian susceptibility to mycobacterial diseases, the long-term picture depends a lot on how severe the immune problem is and which infections occur over time. Long-term effects vary widely, from relatively mild illness between infections to repeated serious infections that leave lasting damage. Some people are affected mainly in childhood, while others continue to have health consequences into adult life.
The main long-term effect of Mendelian susceptibility to mycobacterial diseases is a tendency to have repeated infections from mycobacteria, including illness after the BCG vaccine in some children. Over time, these infections may come back, last longer than expected, or spread beyond one part of the body.
Repeated chest infections can leave lasting changes in the lungs, especially if treatment is delayed or infection is severe. For many, this can mean ongoing cough, reduced exercise tolerance, or scarring seen on scans later in life.
Swollen or infected lymph nodes may become a long-term issue, especially in the neck or under the arms. In some people, nodes stay enlarged for months, drain, or heal with scar tissue.
Some infections affect bones or joints and can lead to pain, trouble walking, or reduced movement that lasts after the infection clears. When this happens during growth, it may also affect posture or normal bone development.
How is it to live with Mendelian susceptibility to mycobacterial diseases?
Living with Mendelian susceptibility to mycobacterial diseases, or MSMD, often means staying unusually alert for infections that most people handle without trouble, especially after exposure to BCG vaccine strains, tuberculosis, or environmental mycobacteria found in soil and water. Daily life can involve regular follow-up with immune and infectious disease specialists, quick attention to fevers, swollen lymph nodes, slow-healing skin problems, or lingering cough, and in some people, long courses of antibiotics or other treatments to prevent serious illness. For families and close contacts, the condition can mean extra planning around vaccines, medical visits, and infection precautions, but with early diagnosis and steady care, many people with MSMD can build stable routines and avoid many complications.
Treatment and drugs
Mendelian susceptibility to mycobacterial diseases is treated by controlling infections quickly and, when possible, addressing the immune problem that makes these infections easier to get. Treatment often includes long courses of antibiotics aimed at mycobacteria, and some people also need other antibiotics or antifungal drugs if they develop additional infections. In certain forms of Mendelian susceptibility to mycobacterial diseases, doctors may use interferon gamma, an immune-signaling treatment that can help the body respond better to germs, and severe cases may sometimes be considered for a stem cell transplant. Not every treatment works the same way for every person, because the best plan depends on the exact gene change, how severe the infections are, and whether related vaccines such as BCG should be avoided in the future.
Can you cure Mendelian susceptibility to mycobacterial diseases?
Usually, no. Mendelian susceptibility to mycobacterial diseases is an inherited problem with the immune system, so treatment mainly aims to prevent and quickly treat infections with antibiotics, other medicines, and careful follow-up rather than fix the gene change itself. For some people with certain severe forms, a bone marrow transplant, which replaces the blood-forming cells that help fight infection, may offer a cure, but it is not right for everyone.
Non-drug treatment
Living with Mendelian susceptibility to mycobacterial diseases often means planning around infection risk, specialist visits, and sometimes procedures rather than relying on day-to-day medicines alone. Managing this condition often includes careful infection prevention, close follow-up with an immune specialist, and support tailored to the exact gene change and how severe the infections have been. Some people do well with monitoring and practical precautions, while others may need more intensive treatment such as a stem cell transplant. Because this condition varies so much, non-drug care is usually individualized.
Everyday steps to lower exposure can help, such as avoiding unpasteurized dairy, limiting contact with people who may have tuberculosis, and using safer food and water habits when traveling. Good wound care and quick attention to fevers or swollen lymph nodes can reduce delays in treatment.
Live vaccines may need special review in people with Mendelian susceptibility to mycobacterial diseases, especially the BCG vaccine used in some countries to prevent tuberculosis. Family members and care teams should check vaccine plans with an immunology specialist so protection is balanced with safety.
Ongoing follow-up with immunology and infectious disease specialists helps track infections, growth, and recovery over time. Early symptoms of Mendelian susceptibility to mycobacterial diseases can be subtle, so regular review can help problems get picked up sooner.
Some infections form enlarged lymph nodes, abscesses, or pockets of infected tissue that need to be drained or removed. Procedures like these can lower pain, improve healing, and help when infection is not clearing well.
Your genes may have an impact on how drugs work for you
In this condition, gene changes do more than raise the risk of unusual infections; they can also affect how well some treatments work, especially medicines meant to boost the body’s defense signals. For example, many living with this condition may benefit from interferon-gamma, a medicine that helps immune cells talk to each other, but it may help little or not at all if the gene change blocks the body from hearing that signal. Antibiotics are still a main part of treatment, but the exact choice is usually guided more by the infection itself than by inherited differences in how the body processes the drug, so genetic testing is most useful here for choosing the overall treatment plan rather than fine-tuning drug dose.
Pharmacological treatments
Treatment for Mendelian susceptibility to mycobacterial diseases usually centers on medicines that fight mycobacterial infections and, in some people, medicines that help the immune system work better. The exact drug plan depends on which germ is causing the infection, how severe it is, and which gene change is involved. Not everyone responds to the same medication in the same way. Many living with Mendelian susceptibility to mycobacterial diseases need care from an infection specialist and an immune specialist working together.
Doctors often use a combination of antibiotics such as rifampin, ethambutol, azithromycin or clarithromycin, and sometimes isoniazid to treat the mycobacterial infection itself. The mix is chosen based on the germ involved, whether it came from the environment or the BCG vaccine, and which medicines the germ is likely to respond to. Treatment is usually long-term because these infections can be hard to clear fully.
Interferon gamma may help some people with Mendelian susceptibility to mycobacterial diseases whose immune pathway can still respond to this signal. It is used as an add-on to antibiotics, not a replacement for them. It is generally not helpful in complete interferon gamma receptor deficiency, because the body cannot receive the signal properly.
Some people with Mendelian susceptibility to mycobacterial diseases also need treatment for other infections, especially Salmonella, yeast, or fungal infections. Depending on the infection, doctors may use antibiotics such as ceftriaxone or ciprofloxacin, or antifungal drugs such as fluconazole or itraconazole. This can matter when early symptoms of Mendelian susceptibility to mycobacterial diseases include repeated infections outside the lungs or skin.
In some cases, long-term preventive antibiotics are used to lower the chance of new infections returning. The choice varies, but may include azithromycin, clarithromycin, or trimethoprim-sulfamethoxazole when a care team thinks the benefit outweighs the risks. Never stop or change a prescription without checking with your healthcare provider.
Genetic influences
For some families, the first clue is a child who becomes unusually ill after the BCG vaccine or after exposure to mycobacteria that usually cause little trouble, and the reason can be inherited. Mendelian susceptibility to mycobacterial diseases is a group of inherited immune disorders caused by changes in genes that help immune cells respond to signals such as interleukin-12 and interferon-γ, including genes like IL12RB1, IFNGR1, IFNGR2, and several others in the same pathway. A change in a gene (mutation or variant) can sometimes affect health, and in this condition it weakens the body’s ability to control certain mycobacterial infections, especially those from BCG, environmental mycobacteria, and in some people tuberculosis. These gene changes may be passed down in different ways, including autosomal recessive, autosomal dominant, and X-linked inheritance, so the pattern in a family can vary. Because the condition is genetic, genetic testing for Mendelian susceptibility to mycobacterial diseases can help confirm the diagnosis, explain the cause of repeated or unusual infections, and identify relatives who may also be affected or carry the same change.
Is Mendelian susceptibility to mycobacterial diseases genetic?
Genetics are central to Mendelian susceptibility to mycobacterial diseases. It is usually caused by inherited gene changes that weaken key immune signals, so genetic testing often helps confirm the diagnosis and can guide family counseling.
Having a genetic risk is not necessarily a diagnosis
It is normal for people to have genetic variants, and these are widespread in the general population. Most of them do not directly affect health and are simply part of the natural variation seen among people. For many genes, carrying a variant tied to a condition suggests a possible connection rather than a definite diagnosis, especially when several genes and environmental factors are involved. Still, in some cases, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with Mendelian susceptibility to mycobacterial diseases, the exact gene change can shape which treatments are most helpful. Most people need antibiotics that target mycobacterial infections, often for a long time, but the inherited immune problem may mean standard drug plans are not enough on their own. Doctors can use your genetic information to help decide whether adding interferon-gamma, a natural immune messenger that can also be given as a medicine, is likely to help. In some genetic types this extra treatment may improve infection control, while in others, especially severe forms where the body cannot respond to interferon-gamma, it is unlikely to work. In those severe forms, early genetic testing for Mendelian susceptibility to mycobacterial diseases can change treatment decisions, including whether a stem cell transplant should be considered. Because the best approach depends on the specific gene involved, treatment is usually tailored by specialists in immune disorders and infectious diseases.
Interactions with other conditions
People living with Mendelian susceptibility to mycobacterial diseases can become much sicker than expected from infections that are usually mild in others, especially after exposure to the BCG vaccine or everyday environmental mycobacteria found in soil and water. This can also overlap with repeated Salmonella infections, and in some families there is a higher risk of certain fungal or viral infections, depending on the exact gene involved. Doctors call it a “comorbidity” when two conditions occur together, but in this case the bigger issue is often that one infection can trigger a wider chain of illness, with fever, swollen lymph nodes, lung problems, or poor weight gain becoming harder to sort out. For many, this can mean an infection in one part of the body does not stay limited and may spread to the blood, bones, liver, or skin. Early symptoms of Mendelian susceptibility to mycobacterial diseases may look like an ordinary infection at first, so related illnesses such as tuberculosis, recurrent pneumonia, or severe complications after BCG vaccination need careful medical review. Because this condition affects how the immune system responds to specific germs, other immune problems are not always present, but infections can interact in ways that make diagnosis and treatment more urgent.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Mendelian susceptibility to mycobacterial diseases?
Because Mendelian susceptibility to mycobacterial diseases mainly causes unusually severe infections from tuberculosis-like germs, doctors often also consider HIV, tuberculosis itself, and other inherited immune system problems such as severe combined immunodeficiency and chronic granulomatous disease. These conditions can also cause repeated infections, swollen lymph nodes, fevers, poor growth, or serious illness after a live vaccine such as the tuberculosis vaccine.
History
Long before doctors understood why some otherwise healthy children became seriously ill after exposure to certain germs, families and clinicians noticed an unusual pattern. A child might have a severe reaction after a routine BCG vaccine, or develop repeated infections from bacteria that usually do not make most people very sick. These puzzling cases were described in medical reports over many years, but at first they were grouped with other immune problems because the underlying cause was not yet clear.
As laboratory medicine improved in the late 20th century, researchers began to see that these infections shared a common thread. People with what is now called Mendelian susceptibility to mycobacterial diseases seemed to have difficulty mounting one particular part of the body’s defense against mycobacteria, a group that includes the bacteria used in the BCG vaccine and those that can cause tuberculosis. In recent decades, awareness has grown, and the condition has been recognized more often in children and adults who had unusually severe, repeated, or hard-to-explain mycobacterial infections.
That shift mattered in everyday care. Instead of treating each infection as a separate mystery, doctors could start to connect the dots when early symptoms of Mendelian susceptibility to mycobacterial diseases appeared, especially after BCG vaccination or exposure to environmental mycobacteria. Over time, research showed that this was not one single illness with exactly the same course in everyone, but a group of related immune conditions with different degrees of severity.
The history of Mendelian susceptibility to mycobacterial diseases also reflects a broader change in medicine: moving from describing what doctors could see to understanding the immune pathways involved. Researchers later identified genetic causes in affected families, which helped confirm that these infections were linked to inherited differences in immune function rather than poor health habits or bad luck. Today, that history helps doctors recognize the condition earlier, guide testing more thoughtfully, and offer better treatment and counseling for people living with Mendelian susceptibility to mycobacterial diseases.